Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RANI
#3919
Rani Therapeutics Holdings, Inc. Class A Common Stock
0.9
6
USD
+14.29%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+14.29%
Mudança mensal
-27.27%
Mudança em 6 meses
+95.92%
Mudança anual
-20.00%
Fechamento anterior
0.8
4
Abrir
0.9
6
Bid
Ask
Mínimo
0.9
6
High
0.9
6
Volume
12
Mercados
Ações
Cuidados de saúde
RANI
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.51 M
33.57 M
47.9 M
97.54 M
99.72 M
—
Valuation ratios
Enterprise value
101.1 M
—
40.37 M
66.01 M
156.87 M
—
Price to earnings ratio
-1.3
-1.21
-0.53
-0.58
-3
-5.32
Price to sales ratio
0.04
—
—
0.01
0.05
—
Price to cash flow ratio
-1.1
-1.05
-0.5
-0.59
-4.77
-6.91
Price to book ratio
19.58
6.23
-7.85
-1.3
2.7
-0.22
Enterprise value to EBITDA ratio
-1.71
—
—
-1.26
-4.3
—
Profitability ratios
Return on assets %
-0.24
-0.3
-0.4
-0.53
-0.18
-1.41
Return on equity %
-2.56
1.36
0.73
0.45
-0.25
2.29
Return on invested capital %
—
—
—
—
-43.85
—
Gross margin %
100
100
—
—
100
—
Operating margin %
-1 454.96
-6 984.3
—
—
-584.19
—
EBITDA margin %
-1 479.18
-7 037.79
—
—
-590.14
—
Net margin %
-870.33
-4 223.26
—
—
-705.34
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.5
0.88
0.54
0.26
4.21
5.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.01
0
0
0.04
0.05
Solvency ratios
Debt to assets ratio
0.67
0.87
1.02
1.34
0
3.22
Debt to equity ratio
12.36
-6.85
-3.09
-1.72
0
-11.66
Long term debt to total assets ratio
0.26
0.25
0.13
0
0
0.38
Long term debt to total equity ratio
4.83
-1.94
-0.4
0
0
-2.34
Per share metrics
Operating cash flow per share
-0.3
-0.24
-0.17
-0.13
0
-0.54
EBIT per share
-0.53
-0.36
-0.3
-0.19
-0.13
-0.98
EBITDA per share
-0.53
-0.36
-0.3
-0.19
-0.13
-0.98
Total debt per share
0.86
0.63
0.49
0.35
0
1.47
Cash per share
0.13
0.3
0.29
0.11
0.28
0.98
Net current asset value per share
1.04
0.53
0.32
0.13
0.81
1.78
Tangible book value per share
69.95
-0.09
-0.15
-0.17
499.11
498.69
Working capital per share
0.35
-0.07
-0.27
-0.37
0.61
-0.09
Book value per share
0.07
-0.09
-0.16
-0.2
0.5
0.05
Notícias
Rani Therapeutics nomeia Sara Kenkare-Mitra como consultora
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript
Rani Therapeutics melhora liquidez no 4T de 2025, mas fica abaixo da previsão de LPA
Rani Therapeutics nomeia Jesper Høiland como chefe de estratégia
Rani Therapeutics promove Alireza Javadi a diretor técnico
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics altera estatuto, reduz poder de voto da Classe B e encerra acordo fiscal
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics anuncia colaboração de US$ 1,085 bilhão com Chugai
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%